Ivy Fertility, which is backed by InTandem Capital Partners, has acquired Seattle-based Pacific NW Fertility and IVF Specialists, a fertility provider group. No financial terms were disclosed.
San Diego, CA, January 6, 2022 – Ivy Fertility, a nationally and internationally recognized innovator in the field of advanced reproductive technologies, in-vitro fertilization, and third-party reproduction that is backed by InTandem Capital Partners, a healthcare services focused private equity firm, announced today it has acquired Pacific NW Fertility and IVF Specialists (“PNWF”), a leading fertility provider group in Seattle, WA.
PNWF is a world-class reproductive center committed to advancing the science of reproduction with the sole purpose of building families with compassion and individualized care. The collective experience of the physicians, embryologists, and the entire team at PNWF has solidified its position as a visionary in the field. Since 2005, PNWF has been a leader in all aspects of fertility care including creating and growing SIMPLIFY, its own donor egg bank.
“In seeking to find a partner who understands our vision and has experience with growth coupled with respect for the patient-centered process, we saw Ivy Fertility as a perfect fit,” said PNWF founder, Dr. Lorna Marshall. “It was clear to us upon our initial meeting with Ivy Fertility that their team builds partnerships with integrity and transparency, and we look forward to a long and successful relationship with the entire Ivy Fertility team.”
Lisa Van Dolah, CEO of Ivy Fertility, said, “Pacific NW Fertility’s team of superior fertility specialists share our vision and goals. My colleagues and I are delighted to have the opportunity to work with a team of compassionate clinicians who are experts in their field.”
“We are thrilled to partner with like-minded colleagues and physicians at Ivy Fertility. We see further potential in Seattle and other regional and international markets, and believe our partnership with Ivy’s expert team will allow us to bring the compassionate care we provide to more people in need,” said PNWF partner, Dr. Julie Lamb.
“Ivy Fertility expressed tremendous respect for what we have already achieved, and they have shown a strong desire to preserve our culture,” said PNWF partner, Dr. Lora Shahine. “I am excited about the future as we work together to bring advancements in our field.”
About Ivy Fertility
Ivy Fertility is nationally and internationally recognized as pioneers and innovators in the field of advanced reproductive technologies, in-vitro fertilization, third-party reproduction, andrology, and research. The company, that is backed by InTandem Capital Partners, a healthcare services focused private equity firm, believes that extraordinary fertility care is about having technical expertise, proven successful outcomes, and the ability to partner with patients to ensure all their needs are met. Ivy Fertility is committed to achieving success and delivering care with innovation and integrity. By developing new procedures, achieving scientific breakthroughs, and teaching the latest techniques, the company upholds its commitment to successful outcomes and continually contributes to the development of the entire fertility community. The Ivy team is passionate about its family-building mission and works tirelessly each day to help its patients achieve their dreams.